Cover Image
市场调查报告书

生菌试验的全球市场 2019年:各产品 (检查装置、消耗品)、各实验项目 (需气性菌、厌氧菌、真菌、孢子)、各用途 、各终端用户的未来预测

Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019

出版商 MarketsandMarkets 商品编码 330568
出版日期 内容信息 英文 146 Pages
订单完成后即时交付
价格
Back to Top
生菌试验的全球市场 2019年:各产品 (检查装置、消耗品)、各实验项目 (需气性菌、厌氧菌、真菌、孢子)、各用途 、各终端用户的未来预测 Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019
出版日期: 2015年05月14日 内容信息: 英文 146 Pages
简介

全球生菌试验市场,2014年达到3亿5440万美元,预计2019年达到5亿6560万美元的规模,其间的年复合成长率(CAGR) 为9.8%。市场成长的主要的推动因素,为医疗设备产业的成长,及制药、生物科技产业的趋势变化,对食品安全的不安扩大,对生命科学领域的研究开发 (R&D) 投资扩大,微生物污染的产品回收数量增加等。另一方面,检查装置的成本高和复杂性,严格的法规,核准时间长等成为抑制市场成长率的要素。现在北美是全球最大的市场,不过,亚太地区也正在急速赶上。

本报告提供全球的生菌试验 (污染微生物数检验) 的市场相关分析、市场基本结构和最新趋势、主要市场促进、阻碍因素、市场规模趋势预测 (今后6年份)、各产品、检验的各类型、各用途、各终端用户、各地区的详细趋势、市场竞争的状态、今后的技术开发、市场发展的方向性、主要企业简介等调查、考察。

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 重要考察

第5章 市场概要

  • 简介
  • 市场区隔
  • 市场动态
    • 推动因素
      • 医疗设备、制药、生物科技产业的成长
      • 食品、饮料的安全性相关疑虑的增加
      • 微生物污染的产品回收数量增加
      • 在生命科学领域活跃的研究开发 (R&D) 投资的动向
      • 医疗产业发达和医疗费的增加
    • 阻碍因素
      • 微生物计数设备的价格高
    • 机会
      • 医药品受托制造厂商 (CMO) 市场机会
      • 新兴国家市场
    • 课题
      • 知识、熟练人力资源的不足
      • 对实验设备、消耗品的严格法规政策

第6章 产业考察

  • 波特的五力分析
  • 策略性基准

第7章 生菌试验市场:各产品

  • 简介
  • 消耗品
    • 培养基、试剂、套件
    • 其他的消耗品
  • 实验器具
    • PCR (聚合酵素链锁反应)
    • 显微镜
    • 自动微生物鉴定系统
    • 其他器具

第8章 生菌试验市场:检验的各类型

  • 简介
  • 需气性菌数
  • 厌氧菌数
  • 真菌/霉菌数
  • 孢子价值

第9章 生菌试验市场:各用途

  • 简介
  • 原料实验
  • 医疗设备实验
  • 中间产品的检验
  • 杀菌验证实验
  • 设备的清洗验证

第10章 生菌试验市场:各终端用户

  • 简介
  • 医药品、生物科技企业
  • 医疗设备厂商
  • 医药品受托制造厂商 (CMO)
  • 食品、饮料及农产品厂商
  • 微生物实验机关

第11章 地区分析

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
  • 亚洲
  • 其他地区 (RoW)

第12章 竞争情形

  • 概要
  • 竞争情形、趋势
    • 企业收购
    • 新产品与服务的销售
    • 产业扩张
    • 其他

第13章 企业简介

  • 简介
  • Charles River Laboratories International, Inc.
    • 产业概要
    • 产品与服务
    • 最近的发展趋势
    • MnM的见解
  • Sigma-Aldrich Corporation
  • SGS S.A.
  • WUXI Pharmatech (Cayman), Inc.
  • Merck & Co., Inc
  • Becton, Dickinson, and Company
  • North American Science Associates, Inc. (NAMSA)
  • Nelson Laboratories, Inc.
  • Pacific Biolabs
  • ATS Labs, Inc.

第14章 附录

图表一览

目录
Product Code: BT 3394

The bioburden testing market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions. On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories. The CMOs segment is expected to grow at the highest CAGR in the coming five years. Growth in this segment will be driven by the rising demand for cost-effective alternatives for manufacturing in emerging as well as developed countries.

The major factors contributing to the growth of the global bioburden testing market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the microbial identification market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards to lengthen the approval process in some countries may hinder the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the bioburden testing market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make necessary decisions regarding product offerings, geographical focus, change in strategic approach, and R&D investments for innovations in products and technologies and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the bioburden testing market. The report analyzes the market by product, test type, application, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the bioburden testing market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the bioburden testing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various bioburden testing products across regions
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the bioburden testing market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Markets Covered
    • 1.3.2. Years Considered for the Study
  • 1.4. Currency
  • 1.5. Limitations
  • 1.6. Market Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Breakdown & Data Triangulation
  • 2.3. Key Data From Secondary Sources
  • 2.4. Key Data From Primary Sources
  • 2.5. Key Industry Insights
  • 2.6. Assumptions for the Study

3. Executive Summary

4. Premium Insights

  • 4.1. Bioburden Testing Market, By Product
  • 4.2. Bioburden Testing Market, for Instruments
  • 4.3. Bioburden Testing Market, By Test Types
  • 4.4. Bioburden Testing Market, By Applications
  • 4.5. Geographic Snapshot
  • 4.6. Bioburden Testing Market, By End Users

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Bioburden Testing Market By Product
    • 5.2.2. Bioburden Testing Market By Test Type
    • 5.2.3. Bioburden Testing Market By Application
    • 5.2.4. Bioburden Testing Market By End User
    • 5.2.5. Bioburden Testing Market By Region
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Growing Medical Device, Pharmaceutical and Biotechnology Industries
      • 5.3.1.2. Increasing Food & Beverage Safety Concerns
      • 5.3.1.3. Increasing Product Recall Due to Microbial Contamination
      • 5.3.1.4. Strong Trend of R&D Investments in Life Sciences
      • 5.3.1.5. Growing Healthcare Industry and Medical Spending
    • 5.3.2. Restrain
      • 5.3.2.1. High Costs of Microbial Enumeration Instruments
    • 5.3.3. Opportunities
      • 5.3.3.1. Opportunity in Contract Manufacturing Market
      • 5.3.3.2. Emerging Economies
    • 5.3.4. Challenges
      • 5.3.4.1. Shortage of Knowledgeable and Skilled Professionals
      • 5.3.4.2. Stringent Regulatory Policies for Instruments and Consumables

6. Industry Insights

  • 6.1. Porter's Five Forces Analysis
    • 6.1.1. Threat From New Entrants
    • 6.1.2. Threat From Substitutes
    • 6.1.3. Bargaining Power of Suppliers
    • 6.1.4. Bargaining Power of Buyers
    • 6.1.5. Intensity of Competitive Rivalry
  • 6.2. Strategic Benchmarking

7. Bioburden Testing Market, By Product

  • 7.1. Introduction
  • 7.2. Consumables
    • 7.2.1. Culture Media, Reagents & Kits
    • 7.2.2. Other Consumables
  • 7.3. Instruments
    • 7.3.1. PCR
    • 7.3.2. Microscopes
    • 7.3.3. Automated Microbial Identification Systems
    • 7.3.4. Other Instruments

8. Bioburden Testing Market, By Test Type

  • 8.1. Introduction
  • 8.2. Aerobic Count
  • 8.3. Anaerobic Count
  • 8.4. Fungi / Mold Count
  • 8.5. Spore Count

9. Bioburden Testing Market, By Application

  • 9.1. Introduction
  • 9.2. Raw Materials Testing
  • 9.3. Medical Devices Testing
  • 9.4. In-Process Material Testing
  • 9.5. Sterilization Validation Testing
  • 9.6. Equipment Cleaning Validation

10. Bioburden Testing Market, By End User

  • 10.1. Introduction
  • 10.2. Pharmaceutical & Biotechnology Companies
  • 10.3. Medical Device Manufacturers
  • 10.4. Contract Manufacturing Organizations (CMOS)
  • 10.5. Manufacturers of Food & Eberage and Agriculture Products
  • 10.6. Microbial Testing Laboratories

11. Geographic Analysis

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
    • 11.2.2. Canada
  • 11.3. Europe
  • 11.4. Asia
  • 11.5. Rest of the World (RoW)

12. Competitive Landscape

  • 12.1. Overview
  • 12.2. Competitive Situation and Trends
    • 12.2.1. Acquisitions
    • 12.2.2. New Product and Service Launches
    • 12.2.3. Expansion
    • 12.2.4. Others

13. Company Profiles

  • 13.1. Introduction
  • 13.2. Charles River Laboratories International, Inc.
    • 13.2.1. Business Overview
    • 13.2.2. Products & Services
    • 13.2.3. Recent Developments
    • 13.2.4. MnM View
  • 13.3. Sigma-Aldrich Corporation
    • 13.3.1. Business Overview
    • 13.3.2. Products & Services
    • 13.3.3. Recent Developments
    • 13.3.4. MnM View
  • 13.4. SGS S.A.
    • 13.4.1. Business Overview
    • 13.4.2. Services
    • 13.4.3. Recent Developments
    • 13.4.4. MnM View
  • 13.5. WUXI Pharmatech (Cayman), Inc.
    • 13.5.1. Business Overview
    • 13.5.2. Services
    • 13.5.3. Recent Developments
    • 13.5.4. MnM View
  • 13.6. Merck & Co., Inc.
    • 13.6.1. Business Overview
    • 13.6.2. Products & Services
    • 13.6.3. Recent Developments
    • 13.6.4. MnM View
  • 13.7. Becton, Dickinson, and Company
    • 13.7.1. Business Overview
    • 13.7.2. Product & Services
    • 13.7.3. Key Strategy
    • 13.7.4. Recent Developments
  • 13.8. North American Science Associates, Inc. (NAMSA)
    • 13.8.1. Business Overview
    • 13.8.2. Services
    • 13.8.3. Key Strategy
    • 13.8.4. Recent Developments
  • 13.9. Nelson Laboratories, Inc.
    • 13.9.1. Business Overview
    • 13.9.2. Services
    • 13.9.3. Key Strategy
    • 13.9.4. Recent Developments
  • 13.10. Pacific Biolabs
    • 13.10.1. Business Overview
    • 13.10.2. Service Portfolio
    • 13.10.3. Key Strategy
    • 13.10.4. Recent Developments
  • 13.11. ATS Labs, Inc.
    • 13.11.1. Business Overview
    • 13.11.2. Services
    • 13.11.3. Key Strategy
    • 13.11.4. Recent Developments

14. Appendix

List of Tables

  • Table 1: Growing Medical Device, Pharmaceutical and Biotechnology Industries Propelling the Growth of the Bioburden Testing Market
  • Table 2: High Costs of Microbial Enumeration Instruments to Hinder Market Growth
  • Table 3: Contract Manufacturing to Create New Growth Opportunities for Market
  • Table 4: Shortage of Knowledgeable and Skilled Professionals A Major Challenge for the Market
  • Table 5: Microbial Limit Testing Market Size, By Product 2012-2019 ($Million)
  • Table 6: Market Size for Consumables, By Type, 2012-2019 ($Million)
  • Table 7: Microbial Limit Testing Market Size for Consumables, By Region, 2012-2019 ($Million)
  • Table 8: North America: Market Size for Consumables, By Country, 2012-2019 ($Million)
  • Table 9: Market Size for Culture Media, Reagents & Kits, By Region, 2012-2019 ($Million)
  • Table 10: North America: Market Size for Culture Media, Reagents & Kits, By Region, 2012-2019 ($Million)
  • Table 11: Market Size for Other Consumables, By Region, 2012-2019 ($Million)
  • Table 12: North America: Market Size for Other Consumables, By Country, 2012-2019 ($Million)
  • Table 13: Bioburden Testing Market Size for Instruments, By Type, 2012-2019 ($Million)
  • Table 14: Market Size for Instruments, By Region, 2012-2019 ($Million)
  • Table 15: North America: Market Size for Instruments, By Country, 2012-2019 ($Million)
  • Table 16: Microbial Limit Testing Market Size for PCR, By Region, 2012-2019 ($Million)
  • Table 17: North America: Bioburden Testing Market Size for PCR, By Country, 2012-2019 ($Million)
  • Table 18: Market Size for Microscopes, By Region, 2012-2019 ($Million)
  • Table 19: North America: Bioburden Testing Market Size for Microscopes, By Country, 2012-2019 ($Million)
  • Table 20: Market Size for Automated Microbial Identification System, By Region, 2012-2019 ($Million)
  • Table 21: North America: Bioburden Testing Market Size for Automated Microbial Identification System, By Country, 2012-2019 ($Million)
  • Table 22: Market Size for Other Instruments, By Region, 2012-2019 ($Million)
  • Table 23: North America: Bioburden Testing Market Size for Other Instruments, By Country, 2012-2019 ($Million)
  • Table 24: Market Size, By Test 2012-2019 ($Million)
  • Table 25: Microbial Limit Testing Market Size for Aerobic Count, By Region, 2012-2019 ($Million)
  • Table 26: North America: Market Size for Aerobic Count, By Country, 2012-2019 ($Million)
  • Table 27: Bioburden Testing Market Size for Anaerobic Count, By Region, 2012-2019 ($Million)
  • Table 28: North America: Bioburden Testing Market Size for Anaerobic Count, By Country, 2012-2019 ($Million)
  • Table 29: Market Size for Fungi/Mold Count, By Region, 2012-2019 ($Million)
  • Table 30: North America: Microbial Limit Testing Market Size for Fungi/Mold Count, By Country, 2012-2019 ($Million)
  • Table 31: Market Size for Spore Count, By Region, 2012-2019 ($Million)
  • Table 32: North America: Bioburden Testing Market Size for Spore Count, By Country, 2012-2019 ($Million)
  • Table 33: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 34: Market Size for Raw Materials Testing, By Region, 2012-2019 ($Million)
  • Table 35: North America: Market Size for Raw Materials Testing, By Country, 2012-2019 ($Million)
  • Table 36: Market Size for Medical Devices Testing, By Region, 2012-2019 ($Million)
  • Table 37: North America: Bioburden Testing Market Size for Medical Devices Testing, By Country, 2012-2019 ($Million)
  • Table 38: Microbial Limit Testing Market Size for In-Process Testing, By Region, 2012-2019 ($Million)
  • Table 39: North America: Bioburden Testing Market Size for In-Process Testing, By Country, 2012-2019 ($Million)
  • Table 40: Microbial Limit Testing Market Size for Sterilization Validation Testing, By Region, 2012-2019 ($Million)
  • Table 41: North America: Market Size for Sterilization Validation Testing, By Country, 2012-2019 ($Million)
  • Table 42: Bioburden Testing Market Size for Equipment Cleaning Validation, By Region, 2012-2019 ($Million)
  • Table 43: North America: Market Size for Equipment Cleaning Validation , By Country, 2012-2019 ($Million)
  • Table 44: Bioburden Testing Market Size, By End User 2012-2019 ($Million)
  • Table 45: Microbial Limit Testing Market Size for Pharmaceutical Companies & Biotechnology Companies, By Region, 2012-2019 ($Million)
  • Table 46: North America: Bioburden Testing Market Size for Pharmaceutical Companies & Biotechnology Companies, By Country, 2012-2019 ($Million)
  • Table 47: Market Size for Medical Device Manufacturers, By Region, 2012-2019 ($Million)
  • Table 48: North America: Bioburden Testing Market Size for Medical Device Manufacturers, By Country, 2012-2019 ($Million)
  • Table 49: Market Size for CMOS, By Region, 2012-2019 ($Million)
  • Table 50: North America: Bioburden Testing Market Size for CMOS, By Country, 2012-2019 ($Million)
  • Table 51: Market Size for Manufacturers of Food & beverage and Agriculture Products, By Region, 2012-2019 ($Million)
  • Table 52: North America: Microbial Limit Testing Market Size for Manufacturers of Food & beverage and Agriculture Products, By Country, 2012-2019 ($Million)
  • Table 53: Market Size for Microbial Testing Labs, By Region, 2012-2019 ($Million)
  • Table 54: North America: Bioburden Testing Market Size for Microbial Testing Labs, By Country, 2012-2019 ($Million)
  • Table 55: Market Size, By Region 2012-2019 ($Million)
  • Table 56: North America: Microbial Limit Testing Market Size, By Country 2012-2019 ($Million)
  • Table 57: North America: Market Size, By Product 2012-2019 ($Million)
  • Table 58: North America: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 59: North America: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 60: North America: Market Size, By Test 2012-2019 ($Million)
  • Table 61: North America: Market Size, By Application 2012-2019 ($Million)
  • Table 62: North America: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 63: U.S.: Market Size, By Product 2012-2019 ($Million)
  • Table 64: U.S.: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 65: U.S.: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 66: U.S.: Market Size, By Test 2012-2019 ($Million)
  • Table 67: U.S.: Market Size, By Application 2012-2019 ($Million)
  • Table 68: U.S.: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 69: Canada: Market Size, By Product 2012-2019 ($Million)
  • Table 70: Canada: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 71: Canada: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 72: Canada: Market Size, By Test 2012-2019 ($Million)
  • Table 73: Canada: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 74: Canada: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 75: Europe: Market Size, By Product 2012-2019 ($Million)
  • Table 76: Europe: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 77: Europe: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 78: Europe: Microbial Limit Testing Market Size, By Test 2012-2019 ($Million)
  • Table 79: Europe: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 80: Europe: Market Size, By End User 2012-2019 ($Million)
  • Table 81: Asia: Market Size, By Product 2012-2019 ($Million)
  • Table 82: Asia: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 83: Asia: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 84: Asia: Market Size, By Test 2012-2019 ($Million)
  • Table 85: Asia: Market Size, By Application 2012-2019 ($Million)
  • Table 86: Asia: Market Size, By End User 2012-2019 ($Million)
  • Table 87: RoW: Market Size, By Product 2012-2019 ($Million)
  • Table 88: RoW: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 89: RoW: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 90: RoW: Market Size, By Test 2012-2019 ($Million)
  • Table 91: RoW: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 92: RoW: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 93: Recent Acquisitions
  • Table 94: Recent Product and Service Launches
  • Table 95: Recent Expansion
  • Table 96: Recent Other Strategies

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Top-Down Approach
  • Figure 3: Bottom-Up Approach
  • Figure 4: Breakdown of Primary Interviews: By Company Type, Designation, and Region
  • Figure 5: Bioburden Testing Market Snapshot, By Product (2014 vs. 2019): Consumables Segment to Dominate the Market During the Forecast Period
  • Figure 6: Market Snapshot, By Test (2014 vs. 2019): Aerobic Count Segment to Witness Highest Growth
  • Figure 7: Market Snapshot, By Application (2014 vs. 2019): Raw Material Testing Segment is Dominant in the Market
  • Figure 8: Pharmeceutical and Biotechnology Companies Held the Largest Share of the Bioburden Testing Market in 2014
  • Figure 9: Global Market, By Region, 2014: North America Accounted for the Largest Share While Asia is Expected to Grow at A Highest CAGR From 2014-2019
  • Figure 10: Consumables Offers Attractive Market Opportunities
  • Figure 11: PCR Segment to Grow at Highest CAGR
  • Figure 12: Culture Media, Reagents and Kits Segment to Grow at Highest CAGR
  • Figure 13: Aerobic Count to Grow at Highest CAGR
  • Figure 14: Raw Material Testing to Account for the Largest Share of the Market
  • Figure 15: Asia to Dominate Bioburden Testing Market
  • Figure 16: Pharmaceutical Companies & Biotechnology Companies Offer Highest Growth Opportunities
  • Figure 17: Bioburden Testing Market Segmentation By Product
  • Figure 18: Market Segmentation By Test Type
  • Figure 19: Market Segmentation By Application
  • Figure 20: Market Segmentation By End User
  • Figure 21: Market Segmentation By Region
  • Figure 22: Growing Medical Device, Pharmaceutical and Biotechnology Industries to Fuel Market Growth
  • Figure 23: Porter's Five Forces Analysis
  • Figure 24: Strategic Benchmarking: Top Players Adopted Acquisitions as Key Growth Strategies
  • Figure 25: Consumables Market to Witness Significant Growth in the Forecast Period
  • Figure 26: Asia to Record the Highest Growth Rate in the Consumables Market
  • Figure 27: Asia Will Grow at Highest CAGR in the Forecast Period 2015-2019
  • Figure 28: Raw Materials Testing Segment to Witness Growth in the Forecast Period
  • Figure 29: CMOS are Expected Grow at the Highest CAGR
  • Figure 30: Asian Market for Bioburden Testing is Expected to Grow at Highest Rate From 2014 to 2019
  • Figure 31: Asia: High Demand for Veterinary Software From End Users
  • Figure 32: North America: Market Snapshot
  • Figure 33: Major Players Adopted Acquisitions and New Product and Service Launches as A Key Growth Strategy Between 2012 and 2014
  • Figure 34: Market Evolution Framework: Acquisitions and Product and Service Launches Fuelled Market Growth
  • Figure 35: Acquisitions, New Product and Service Launches Were Preferred Strategies for Market Players
  • Figure 36: Geographic Revenue Mix of Top 4 Market Players
  • Figure 37: Charles River Laboratories International, Inc.: Company Snapshot
  • Figure 38: Sigma-Aldrich Corporation: Company Snapshot
  • Figure 39: SGS SA: Company Snapshot
  • Figure 40: WUXI Pharmatech (Cayman) Inc.: Company Snapshot
  • Figure 41: Merck & Co., Inc.: Company Snapshot
  • Figure 42: Becton, Dickinson and Company: Company Snapshot
  • Figure 43: North American Science Associates, Inc.: Company Snapshot
  • Figure 44: Nelson Laboratories Inc.: Company Snapshot
  • Figure 45: Pacific Biolabs: Company Snapshot
  • Figure 46: ATS Labs, Inc.: Company Snapshot
Back to Top